Compass Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70
Closed -$1.75K 203
2025
Q4
$1.75K Buy
70
+1
+1% +$25 ﹤0.01% 262
2025
Q3
$1.76K Sell
69
-311
-82% -$7.68K ﹤0.01% 270
2025
Q2
$9.21K Sell
380
-170
-31% -$3.96K ﹤0.01% 199
2025
Q1
$13.9K Buy
550
+484
+733% +$12.7K 0.01% 156
2024
Q4
$1.74K Buy
+66
New +$1.79K ﹤0.01% 184

Other funds holding PFE

Compass Financial Services's PFE Position: Q1 2026 in Review

Compass Financial Services sold out of Pfizer (PFE) in Q1 2026, closing a stake of 70 shares — an estimated $1.75K sold.

Compass Financial Services first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $13.9K in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Compass Financial Services reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Compass Financial Services sold 70 Pfizer shares in Q1 2026, an estimated $1.75K.
  • Compass Financial Services first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
  • Compass Financial Services's Pfizer position peaked at $13.9K in Q1 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Compass Financial Services's 13F filing for Q1 2026, filed 1 May 2026.